{"id":825478,"date":"2025-03-13T09:28:07","date_gmt":"2025-03-13T13:28:07","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/aclarion-provides-shareholder-update\/"},"modified":"2025-03-13T09:28:07","modified_gmt":"2025-03-13T13:28:07","slug":"aclarion-provides-shareholder-update","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/aclarion-provides-shareholder-update\/","title":{"rendered":"Aclarion Provides Shareholder Update"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">BROOMFIELD, Colo., March  13, 2025  (GLOBE NEWSWIRE) &#8212; Aclarion, Inc.,<strong>\u00a0(\u201cAclarion\u201d or the \u201cCompany\u201d) (Nasdaq: ACON, ACONW)<\/strong>,\u00a0a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today that it has issued an 8k filing that provides an update for stakeholders to review. The filing can be viewed <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=jNdkH-pQiaqjMuR807_kKx-Wh1KBMkCN_FXcj7cuXJs2s1y88u79GJDYS6TwwOhcKR9M_vw8zTtCSkOSfDVazUdKzMleJtGUGNk7DfxVwDFe9HIurUS-w0pvFf94E5kS\" rel=\"nofollow\" target=\"_blank\"><strong><u>here<\/u><\/strong><\/a>.<\/p>\n<p align=\"justify\">The Company intends on filing its 10K by the end of March and plans to provide a more in-depth Corporate Update at that time.<\/p>\n<p>\n        <strong>About Aclarion, Inc.<\/strong>\n      <\/p>\n<p align=\"justify\">Aclarion is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (\u201cMRS\u201d), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing the chronic low back pain market with Nociscan, the first, evidence-supported, SaaS platform to noninvasively help physicians distinguish between painful and nonpainful discs in the lumbar spine. Through a cloud connection, Nociscan receives magnetic resonance spectroscopy (MRS) data from an MRI machine for each lumbar disc being evaluated. In the cloud, proprietary signal processing techniques extract and quantify chemical biomarkers demonstrated to be associated with disc pain. Biomarker data is entered into proprietary algorithms to indicate if a disc may be a source of pain. When used with other diagnostic tools, Nociscan provides critical insights into the location of a patient\u2019s low back pain, giving physicians clarity to optimize treatment strategies. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=Dhu7ZHupTFoRAFbfzMF5dd02kZ3554oYxs9ykaZ-QtzaU3lXXbKlUSP18hEDd04fxiryZpj5azQK3huQC6b6TslXfdWMD2LI42WwSy_2tR4=\" rel=\"nofollow\" target=\"_blank\"><u>www.aclarion.com<\/u><\/a>.<\/p>\n<p>\n        <strong>Forward-Looking Statements<\/strong>\n      <\/p>\n<p align=\"justify\">This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934 about the Company\u2019s current expectations about future results, performance, prospects and opportunities. Statements that are not historical facts, such as \u201canticipates,\u201d \u201cbelieves\u201d and \u201cexpects\u201d or similar expressions, are forward-looking statements. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the Company\u2019s current plans and expectations, as well as future results of operations and financial condition. These and other risks and uncertainties are discussed more fully in our filings with the Securities and Exchange Commission. Readers are encouraged to review the section titled \u201cRisk Factors\u201d in the Company\u2019s Annual Report on Form 10-K for the year ended December 31, 2023, as well as other disclosures contained in the Prospectus and subsequent filings made with the Securities and Exchange Commission. Forward-looking statements contained in this announcement are made as of this date and the Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.<\/p>\n<p>\n        <strong>Investor Contacts:<\/strong>\n      <\/p>\n<p>Kirin M. Smith<br \/>PCG Advisory, Inc.<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=6Ubr4ui7bTv5IjIuk68Vjc4mf8aSFnn2zRZFamaTiaOkMPR-ACFoXbQhVme4GJ7YFGsTlY-pLuVGhqUVqj3VASV9JSbSGhxjjFJKYwKQRq4=\" rel=\"nofollow\" target=\"_blank\"><u>ksmith@pcgadvisory.com<\/u><\/a><\/p>\n<p>\n        <strong>Media Contacts:<\/strong>\n      <\/p>\n<p>Jennie Kim<br \/>SPRIG Consulting<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=lp08gE7lFKpVxgGe8Z4WOqMrnkusbrUkJi0rRBLstQToGEaQyOlOahmgKaA7u5M156CpXXUs0AH5sUiwXsHJ8vKNKN_ZRNGCdneaRipbONv3HfssPsCTxw3OFhTdrJj2\" rel=\"nofollow\" target=\"_blank\"><u>jennie@sprigconsulting.com<\/u><\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5Mzc5NiM2ODA0MjU0IzUwMDEzMjI4Ng==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/YWY0OTc1Y2YtMjEyMC00MTg3LTgxYTQtYzYxNmUzMjVhZDc0LTUwMDEzMjI4Ni0yMDI1LTAzLTEzLWVu\/tiny\/Aclarion-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>BROOMFIELD, Colo., March 13, 2025 (GLOBE NEWSWIRE) &#8212; Aclarion, Inc.,\u00a0(\u201cAclarion\u201d or the \u201cCompany\u201d) (Nasdaq: ACON, ACONW),\u00a0a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today that it has issued an 8k filing that provides an update for stakeholders to review. The filing can be viewed here. The Company intends on filing its 10K by the end of March and plans to provide a more in-depth Corporate Update at that time. About Aclarion, Inc. Aclarion is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (\u201cMRS\u201d), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aclarion-provides-shareholder-update\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Aclarion Provides Shareholder Update&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-825478","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Aclarion Provides Shareholder Update - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/aclarion-provides-shareholder-update\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Aclarion Provides Shareholder Update - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"BROOMFIELD, Colo., March 13, 2025 (GLOBE NEWSWIRE) &#8212; Aclarion, Inc.,\u00a0(\u201cAclarion\u201d or the \u201cCompany\u201d) (Nasdaq: ACON, ACONW),\u00a0a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today that it has issued an 8k filing that provides an update for stakeholders to review. The filing can be viewed here. The Company intends on filing its 10K by the end of March and plans to provide a more in-depth Corporate Update at that time. About Aclarion, Inc. Aclarion is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (\u201cMRS\u201d), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing &hellip; Continue reading &quot;Aclarion Provides Shareholder Update&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/aclarion-provides-shareholder-update\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-13T13:28:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5Mzc5NiM2ODA0MjU0IzUwMDEzMjI4Ng==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aclarion-provides-shareholder-update\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aclarion-provides-shareholder-update\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Aclarion Provides Shareholder Update\",\"datePublished\":\"2025-03-13T13:28:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aclarion-provides-shareholder-update\\\/\"},\"wordCount\":471,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aclarion-provides-shareholder-update\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5Mzc5NiM2ODA0MjU0IzUwMDEzMjI4Ng==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aclarion-provides-shareholder-update\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aclarion-provides-shareholder-update\\\/\",\"name\":\"Aclarion Provides Shareholder Update - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aclarion-provides-shareholder-update\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aclarion-provides-shareholder-update\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5Mzc5NiM2ODA0MjU0IzUwMDEzMjI4Ng==\",\"datePublished\":\"2025-03-13T13:28:07+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aclarion-provides-shareholder-update\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aclarion-provides-shareholder-update\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aclarion-provides-shareholder-update\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5Mzc5NiM2ODA0MjU0IzUwMDEzMjI4Ng==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTM5Mzc5NiM2ODA0MjU0IzUwMDEzMjI4Ng==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/aclarion-provides-shareholder-update\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Aclarion Provides Shareholder Update\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Aclarion Provides Shareholder Update - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/aclarion-provides-shareholder-update\/","og_locale":"en_US","og_type":"article","og_title":"Aclarion Provides Shareholder Update - Market Newsdesk","og_description":"BROOMFIELD, Colo., March 13, 2025 (GLOBE NEWSWIRE) &#8212; Aclarion, Inc.,\u00a0(\u201cAclarion\u201d or the \u201cCompany\u201d) (Nasdaq: ACON, ACONW),\u00a0a healthcare technology company that is leveraging biomarkers and proprietary augmented intelligence (AI) algorithms to help physicians identify the location of chronic low back pain, announced today that it has issued an 8k filing that provides an update for stakeholders to review. The filing can be viewed here. The Company intends on filing its 10K by the end of March and plans to provide a more in-depth Corporate Update at that time. About Aclarion, Inc. Aclarion is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (\u201cMRS\u201d), proprietary signal processing techniques, biomarkers, and augmented intelligence algorithms to optimize clinical treatments. The Company is first addressing &hellip; Continue reading \"Aclarion Provides Shareholder Update\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/aclarion-provides-shareholder-update\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-13T13:28:07+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5Mzc5NiM2ODA0MjU0IzUwMDEzMjI4Ng==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aclarion-provides-shareholder-update\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aclarion-provides-shareholder-update\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Aclarion Provides Shareholder Update","datePublished":"2025-03-13T13:28:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aclarion-provides-shareholder-update\/"},"wordCount":471,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aclarion-provides-shareholder-update\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5Mzc5NiM2ODA0MjU0IzUwMDEzMjI4Ng==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aclarion-provides-shareholder-update\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/aclarion-provides-shareholder-update\/","name":"Aclarion Provides Shareholder Update - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aclarion-provides-shareholder-update\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aclarion-provides-shareholder-update\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5Mzc5NiM2ODA0MjU0IzUwMDEzMjI4Ng==","datePublished":"2025-03-13T13:28:07+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aclarion-provides-shareholder-update\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/aclarion-provides-shareholder-update\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aclarion-provides-shareholder-update\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5Mzc5NiM2ODA0MjU0IzUwMDEzMjI4Ng==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTM5Mzc5NiM2ODA0MjU0IzUwMDEzMjI4Ng=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/aclarion-provides-shareholder-update\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Aclarion Provides Shareholder Update"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/825478","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=825478"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/825478\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=825478"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=825478"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=825478"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}